Skip to main content
Premium Trial:

Request an Annual Quote

CDC Buys $1M Worth of Advion's NanoMate Instruments for Chemical Terrorism Program

NEW YORK (GenomeWeb News) — The Centers for Disease Control and Prevention will pay $1 million to buy eight of Advion BioSystems’ mass spectrometry-based TriVersa NanoMate units, the firm said today.
 
The systems will be used at Level One state testing sites in the Laboratory Resource Network, the CDC’s national chemical terrorism program.
 
According to Advion, a subsidiary of ADvion BioSciences, the CDC already has three NanoMate units installed in the LRN. The instruments will be used to conduct early response screening for chemical terrorism analyses using chip-based nanoelectrospray mass spectrometry.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.